Atlas Trials

A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

Clinical trial NCT05054309 · COMPLETED

Trial details

NCT number
NCT05054309
Sponsor
Société des Produits Nestlé (SPN)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
IBS - Irritable Bowel Syndrome
Start date
2022-02-11
Primary completion
2024-12-04
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.